Hemodynamic support devices should be considered prophylactically in selected high-risk cases or used if a patient develops hemodynamic compromise during the procedure. Long, noncompliant balloons are often needed for lesion preparation after crossing and second-generation drug-eluting stents are used in CTO PCI to minimize the risk for restenosis. Radiation scatter shields can minimize operator radiation exposure. Intravascular ultrasonography and/or optical coherence tomography can assist with CTO crossing and stenting optimization, whereas covered stents and coils with appropriate delivery microcatheters are necessary for treating perforations, which is the most common complication of CTO PCI. Small balloons, various microcatheters, laser, atherectomy, and scoring balloons are often needed for balloon-uncrossable and balloon-undilatable lesions. Guide catheter extensions can increase support and also facilitate retrograde CTO PCI. Specialized equipment can facilitate dissection/reentry, and snares may be needed for retrograde guidewire externalization. CTO crossing should always be performed by advancing a guidewire through a microcatheter (preferred) or over-the-wire balloon, with careful selection of guidewires based on the lesion characteristics. CTO PCI equipment can be grouped into 12 categories: (1) sheaths, (2) guide catheters and guide catheter extensions, (3) microcatheters and support catheters, (4) guidewires, (5) dissection/reentry equipment, (6) snares, (7) equipment for balloon-uncrossable and balloon-undilatable lesions, (8) intravascular imaging, (9) equipment for managing complications, (10) equipment for minimizing operator radiation exposure, (11) balloons/stents, and (12) hemodynamic support devices.
GUIDELINER NAVIGATION CATHETER FULL
GuideLiner Coast is in limited market release currently, and full market release is expected later this year.Availability of dedicated equipment and familiarity with its use are critical for successfully and safely performing chronic total occlusion (CTO) percutaneous coronary interventions (PCIs). “The Triumph Catheter and the GuideLiner Coast Catheter reflect our focus on providing physicians with new choices and technologies engineered to address unmet clinical needs, personal preference and technique, and the challenges of complex anatomy.” “Teleflex is committed to providing more options in the cath lab to help interventionalists address the specific needs of their patients,” said Scott Holstine, president and GM of Teleflex’s Interventional business unit. It was was first used in a clinical procedure at the UW Medicine Heart Institute. The GuideLiner Coast catheter adds a hydrophilic option to Teleflex’s guide extension portfolio. “The Triumph Catheter’s nitinol ports and cage bring navigation and control to a new level, and I am excited that Teleflex will enable interventional cardiologists to readily access this important technology.”
“In complex cases, the ability to better navigate tortuous anatomy has long been a challenge,” Dr. It was designed in collaboration with Bill Nicholson, MD, Director of Interventional Cardiology at Emory Healthcare. The Triumph catheter features six wire exit ports for precise wire advancement and clear visualization.
Food and Drug Administration (FDA) 510(k) clearance for its Triumph catheter and achieved first clinical use of its GuideLiner Coase catheter.
0 kommentar(er)
